Felix Theeuwes

CIK 1134642 · View on SEC EDGAR ↗

Insider

First SEC filing: May 16, 2005 · Latest: May 16, 2005

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 5 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

5 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Sept. 14, 2004 INO P 1,029 $8.80 $9,055 1,029 Direct Acquired -99.7% (price as of 2026-08-21)
Sept. 14, 2004 INO P 2 $11764.71 $23,529 2 Direct Acquired -100.0% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
June 7, 2006 INO Inovio Biomedical Corporation Common Stock Option Inovio Biomedical Corporation Common Stock (25,000) $2.23 June 7, 2016 25,000 Acquired
May 13, 2005 INO Inovio Biomedical Corporation Common Stock Inovio Biomedical Corporation Common Stock (10,000) $3.34 May 12, 2015 10,000 Acquired
Sept. 14, 2004 INO Genetronics Biomedical Corporation Common Stock Warrants Genetronics Biomedical Corporation Common Stock $8.80 May 10, 2009 1,029 Acquired
Aug. 6, 2004 INO Common Stock Common Stock (20,000) $0.93 Aug. 5, 2014 20,000 Acquired
June 17, 2004 INO Common Stock Common Stock (35,000) $1.33 June 16, 2014 35,000 Acquired
Aug. 8, 2003 INO Common Stock Common Stock (91,250) $0.63 Aug. 7, 2013 91,250 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).